Psychiatry is in the midst of a technological transformation. Beyond new medications and devices, the field is being reshaped by faster treatment regimens, biologically targeted diagnostics, and artificial intelligence (AI)...
Half of patients with major depression don’t respond adequately to their first antidepressant. After assuring proper diagnosis, adequate dose, and sufficient duration, providers face a critical decision: switch to a...
The Patient Health Questionnaire-9 (PHQ-9) was developed by Pfizer in 2001 as a fast depression screening tool for primary care. Multiple studies have validated its use since then, but the...
Join our growing community and receive invaluable resources directly.
Receive our bi-weekly newsletter packed with resilience tools and breakthroughs.
Engage in anonymous peer support and connect with others on a similar path.
Share your powerful recovery journey and inspire others.
Join our growing community and receive our bi-weekly newsletter packed with resilience tools and breakthroughs.
"*" indicates required fields
